Hepatitis B Surface Antigen In Human Immuno Deficiency Virus Positive Patients In Bida, North Central Nigeria.

A prospective cross-sectional and analytical study was carried out to establish the prevalence of hepatitis B surface antigen in HIV infected population in Bida –North Central Nigeria.A total of 250 HIV seropositive patients comprising of 118 (47.2%) males and 132 (52.8%) females paticipated in this study.The age range of participants was 18 65 years. Rapid Chromatogenic Enzyme Immuno Assay (EIA) kit was used for the detection of Hepatitis B surface antigen in the serum samples. Our result shows that thirty three (13.2%) of the patients are Hepatitis B surface antigen seropositive. Co-infection of hepatitis were more in female 23(17.6%) than male 10(8.4%) subjects. Statistical analysis showed significant difference (p 0.05). Routine screening of patients with HIV infection for Hepatitis B surface should be encouraged for early diagnosis.The high prevalence is a reflection of the endemicity of hepatitis B viral infection in Bida, North central Nigeria.HBV, Co-infection, HIV,Nigeria.

[1]  I. Adewole,et al.  Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. , 2008, Annals of hepatology.

[2]  F. Carrat,et al.  Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY) , 2007, AIDS.

[3]  J. Forbi,et al.  The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. , 2007, Memorias do Instituto Oswaldo Cruz.

[4]  O. Kirk,et al.  Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. , 2006, Archives of internal medicine.

[5]  R. Chung.  Hepatitis C and B viruses: the new opportunists in HIV infection. , 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[6]  V. Soriano,et al.  Management of chronic hepatitis B and C in HIV-coinfected patients. , 2006, The Journal of antimicrobial chemotherapy.

[7]  M. Alter,et al.  Epidemiology of viral hepatitis and HIV co-infection. , 2006, Journal of hepatology.

[8]  C. Uneke,et al.  Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. , 2005, Memorias do Instituto Oswaldo Cruz.

[9]  A. Wohl,et al.  Survival in patients with HIV infection and viral hepatitis B or C: a cohort study , 2004, AIDS.

[10]  J. Seeley,et al.  Gender and HIV/AIDS impact mitigation in sub-Saharan Africa — recognising the constraints , 2004, SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance.

[11]  C. Muller,et al.  Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa * , 2001, Journal of medical virology.

[12]  M. Battegay,et al.  Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study , 2000, The Lancet.

[13]  J. Main,et al.  Interactions of the Human Immunodeficiency Virus and the Hepatotropic Viruses , 1992, Seminars in liver disease.

[14]  M. Carroll,et al.  Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. , 1989, The American journal of medicine.